NASDAQ:ATRI - Atrion Stock Price, Forecast & News

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Atrion announced a quarterly dividend on Tuesday, November 12th. Shareholders of record on Monday, December 2nd will be paid a dividend of $1.55 per share on Monday, December 16th. This represents a $6.20 annualized dividend and a yield of 0.86%. The ex-dividend date is Friday, November 29th. View Atrion's Dividend History.

Atrion Co. (NASDAQ:ATRI) issued its quarterly earnings data on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a net margin of 23.43% and a return on equity of 16.45%. View Atrion's Earnings History.

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Atrion.

News articles about ATRI stock have trended extremely negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Atrion earned a media sentiment score of -4.3 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Atrion.

Atrion saw a drop in short interest in December. As of December 31st, there was short interest totalling 101,500 shares, a drop of 7.6% from the December 15th total of 109,800 shares. Based on an average trading volume of 10,500 shares, the days-to-cover ratio is presently 9.7 days. Currently, 7.1% of the shares of the stock are short sold. View Atrion's Current Options Chain.

Some companies that are related to Atrion include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Antares Pharma (ATRS), Cerus (CERS), Anika Therapeutics (ANIK), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include ABM Industries (ABM), International Paper (IP), AT&T (T), Westrock (WRK), Exxon Mobil (XOM), Gilead Sciences (GILD), Methanex (MEOH), Pattern Energy Group (PEGI), Walgreens Boots Alliance (WBA) and AbbVie (ABBV).

Atrion's stock is owned by a number of of retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (1.01%), Pennsylvania Trust Co (0.56%), California Public Employees Retirement System (0.19%), Virginia Retirement Systems ET AL (0.09%), Hudson Valley Investment Advisors Inc. ADV (0.05%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland, John P Stupp Jr and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion.

ATRI stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, California Public Employees Retirement System, Nisa Investment Advisors LLC, Virginia Retirement Systems ET AL and Pennsylvania Trust Co. Company insiders that have sold Atrion company stock in the last year include John P Stupp Jr and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion.

ATRI stock was purchased by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp and Hudson Valley Investment Advisors Inc. ADV. View Insider Buying and Selling for Atrion.

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ATRI stock can currently be purchased for approximately $717.93.

Atrion has a market capitalization of $1.33 billion and generates $152.45 million in revenue each year. Atrion employs 570 workers across the globe.View Additional Information About Atrion.

The official website for Atrion is http://www.atrioncorp.com/.

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]